BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17915423)

  • 1. [Endocrinology and nuclear medicine aspects of the treatment of thyroid tumours].
    Vicek P
    Vnitr Lek; 2007; 53(7-8):807-11. PubMed ID: 17915423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human TSH-assisted radioactive iodine remnant ablation achieves short-term clinical recurrence rates similar to those of traditional thyroid hormone withdrawal.
    Tuttle RM; Brokhin M; Omry G; Martorella AJ; Larson SM; Grewal RK; Fleisher M; Robbins RJ
    J Nucl Med; 2008 May; 49(5):764-70. PubMed ID: 18413378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.
    Giovanella L; Ceriani L; Suriano S; Ghelfo A; Maffioli M
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid nodules and cancers in children.
    Josefson J; Zimmerman D
    Pediatr Endocrinol Rev; 2008 Sep; 6(1):14-23. PubMed ID: 18806721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coming of age: recombinant human thyroid-stimulating hormone as a preparation for (131)i therapy in thyroid cancer.
    Robbins RJ; Pentlow KS
    J Nucl Med; 2003 Jul; 44(7):1069-71. PubMed ID: 12843222
    [No Abstract]   [Full Text] [Related]  

  • 6. Radioiodine treatment for malignant thyroid disease.
    Berg G
    Acta Oncol; 2006; 45(8):1041-5. PubMed ID: 17118836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How the availability of recombinant human TSH has changed the management of patients who have thyroid cancer.
    Schlumberger M; Ricard M; De Pouvourville G; Pacini F
    Nat Clin Pract Endocrinol Metab; 2007 Sep; 3(9):641-50. PubMed ID: 17710085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Classification of the malignant struma and its combined treatment].
    Röher HD
    Med Welt; 1969 Jun; 26():1480-4. PubMed ID: 5801900
    [No Abstract]   [Full Text] [Related]  

  • 9. Quality of life changes and clinical outcomes in thyroid cancer patients undergoing radioiodine remnant ablation (RRA) with recombinant human TSH (rhTSH): a randomized controlled study.
    Taïeb D; Sebag F; Cherenko M; Baumstarck-Barrau K; Fortanier C; Farman-Ara B; De Micco C; Vaillant J; Thomas S; Conte-Devolx B; Loundou A; Auquier P; Henry JF; Mundler O
    Clin Endocrinol (Oxf); 2009 Jul; 71(1):115-23. PubMed ID: 18803678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new age for recombinant human thyroid-stimulating hormone?
    Medvedec M
    J Nucl Med; 2009 May; 50(5):832; author reply 832-3. PubMed ID: 19372486
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnosis, treatment, prognostic factors and long-term outcome in papillary thyroid carcinoma.
    Pelizzo MR; Merante Boschin I; Toniato A; Pagetta C; Casal Ide E; Mian C; Rubello D
    Minerva Endocrinol; 2008 Dec; 33(4):359-79. PubMed ID: 18923371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview on the use of recombinant human thyrotropin in thyroid cancer of follicular cell origin.
    Zanotti-Fregonara P; Toubert ME; Taieb D; Ravasi L; Rubello D; Hindie E
    Minerva Endocrinol; 2008 Jun; 33(2):53-65. PubMed ID: 18332849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human TSH in differentiated thyroid cancer: a nuclear medicine perspective.
    Zanotti-Fregonara P; Rubello D; Hindié E
    Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1397-9. PubMed ID: 18470514
    [No Abstract]   [Full Text] [Related]  

  • 14. Recombinant human TSH associated with radioiodine does not have further effects on thyroid volume and function after 2 years.
    Paz-Filho GJ; Mesa CO; Carvalho GA; Goedert CA; Graf H
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):345-6. PubMed ID: 18167135
    [No Abstract]   [Full Text] [Related]  

  • 15. Contemporary management of papillary carcinoma of the thyroid gland.
    Rosenbaum MA; McHenry CR
    Expert Rev Anticancer Ther; 2009 Mar; 9(3):317-29. PubMed ID: 19275510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Papillary thyroid carcinoma metastatic to the pituitary gland.
    Masiukiewicz US; Nakchbandi IA; Stewart AF; Inzucchi SE
    Thyroid; 1999 Oct; 9(10):1023-7. PubMed ID: 10560958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical review 156: Recombinant human thyrotropin and thyroid cancer management.
    Robbins RJ; Robbins AK
    J Clin Endocrinol Metab; 2003 May; 88(5):1933-8. PubMed ID: 12727936
    [No Abstract]   [Full Text] [Related]  

  • 18. Nonsurgical treatment of thyroid tumours and its results.
    Scott JS
    Proc R Soc Med; 1974 Nov; 67(11):1106-7. PubMed ID: 4438292
    [No Abstract]   [Full Text] [Related]  

  • 19. [Role of diagnostic and therapeutic tools in the definition of differentiated thyroid carcinoma (1800-1950)].
    Fragu P
    Bull Cancer; 2000 Feb; 87(2):145-54. PubMed ID: 10705285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiated thyroid carcinoma in childhood.
    Dottorini ME
    Rays; 2000; 25(2):245-55. PubMed ID: 11370542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.